Company to view next
Generic selectors
Exact matches only
Search in title
Search in content

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 and AUTO8 for the treatment of multiple myeloma; AUTO1/22 for the treatment of dual-targeting CAR-T; AUTO3NG for the treatment of hematological cancer; AUTO4 and AUTO5 for T cell lymphoma; AUTO6NG for the treatment of programmed T cell therapies; AUTO6 for the treatment of neuroblastoma; and AUTO7 for the treatment of prostate cancer. Autolus Therapeutics plc was founded in 2014 and is headquartered in London, the United Kingdom.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

376

Address:

Autolus Therapeutics plc Forest House 58 Wood Lane White City London W12 7RZ United Kingdom

Website:

http://www.autolus.com

Phone:

44 20 3829 6230

Leave a comment

Your email address will not be published. Required fields are marked *